Palvella Therapeutics, Inc.
PVLANASDAQHealthcare● Active
$105.25
$-3.42(-3.15%)
Market Cap$1.2B
P/E Ratio—
52W High$151.18
52W Low$20.2
Palvella Therapeutics, Inc.（PVLA）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PVLA · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.03B | $0.03B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.02B | $0.03B |
| Gross Margin %(computed) | — | — | — | 89.27% | 92.46% |
| Operating Expenses | |||||
| R&D Expenses | $0.02B | $0.01B | $0.01B | $0.05B | $0.06B |
| G&A Expenses | $0.02B | $0.01B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.04B | $0.01B | $0.01B | $0.07B | $0.08B |
| Operating Income | ($0.04B) | ($0.01B) | ($0.01B) | ($0.04B) | ($0.05B) |
| Operating Margin %(computed) | — | — | — | -167.84% | -164.97% |
| Interest Income | $0.00B | $0.00B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.04B) | ($0.02B) | $0.02B | ($0.03B) | ($0.05B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.04B) | ($0.02B) | $0.02B | ($0.03B) | ($0.05B) |
| Net Margin %(computed) | — | — | — | -128.47% | -145.58% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.71 | $-7.83 | $14.74 | $-29.61 | $-56.69 |
| Wtd Avg Shares | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.04B) | ($0.01B) | $0.02B | ($0.03B) | ($0.04B) |
| EBITDA Margin %(computed) | — | — | — | -117.74% | -138.04% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Palvella Therapeutics, Inc.
关于Palvella Therapeutics, Inc.（PVLA）损益表
Palvella Therapeutics, Inc.（PVLA）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，PVLA实现营收$0.00B，毛利润$0.00B（毛利率—），净利润($0.04B)（净利率—）。
常见问题
PVLA · 4 问Palvella Therapeutics, Inc.（PVLA）2025财年营收为$0.00B，同比down—%。
PVLA revenuePVLA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08